Lantheus Holdings (LNTH) Receivables (2014 - 2026)

Lantheus Holdings' (LNTH) quarterly Receivables came in at $355.7 million in Q1 2026, up 1.98% year-on-year from $348.7 million in Q1 2025, and down 0.83% on a QoQ basis from $358.6 million in Q4 2025.

Lantheus Holdings (LNTH) Receivables (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 13 years of Receivables data on file, last reported at $355.7 million in Q1 2026.

  • On a quarterly basis, Receivables rose 1.98% year-over-year to $355.7 million in Q1 2026; TTM through Mar 2026 was $355.7 million, a 1.98% increase from a year earlier, with the FY2025 full-year figure at $358.6 million, up 11.64% from the prior year.
  • Receivables for Q1 2026 stood at $355.7 million, down from $358.6 million in the prior quarter.
  • Over the last five years, Receivables for LNTH reached as high as $372.3 million in Q2 2024 and fell as low as $172.3 million in Q1 2022.
  • Historically, Receivables has averaged $289.6 million across 5 years, with a median of $321.3 million in 2024.
  • Across the five-year window, Receivables surged 240.76% in 2022 and retreated 9.59% in 2025, its largest moves.
  • Year by year, Receivables stood at $213.4 million in 2022, then jumped by 33.22% to $284.3 million in 2023, then climbed by 13.0% to $321.3 million in 2024, then climbed by 11.64% to $358.6 million in 2025, then slipped by 0.83% to $355.7 million in 2026.
  • Per Business Quant data, the three most recent Receivables figures were $355.7 million in Q1 2026, $358.6 million in Q4 2025, and $351.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 2.99 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 3.39 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 1.51 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 6.46 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 312.00 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 15.29 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 3.58 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 768.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 1.15 Bn
10 Lantheus Holdings 6.72 Bn 6.22 Bn 230.92 Mn 355.67 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 355.67 Mn
Dec 31, 2025 358.64 Mn
Sep 30, 2025 351.38 Mn
Jun 30, 2025 336.58 Mn
Mar 31, 2025 348.75 Mn
Dec 31, 2024 321.26 Mn
Sep 30, 2024 329.34 Mn
Jun 30, 2024 372.29 Mn
Mar 31, 2024 337.39 Mn
Dec 31, 2023 284.29 Mn
Sep 30, 2023 259.20 Mn
Jun 30, 2023 256.28 Mn
Mar 31, 2023 242.11 Mn
Dec 31, 2022 213.40 Mn
Sep 30, 2022 197.28 Mn
Jun 30, 2022 187.05 Mn
Mar 31, 2022 172.28 Mn
Dec 31, 2021 89.34 Mn
Sep 30, 2021 64.05 Mn
Jun 30, 2021 54.89 Mn